nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PDE7A—lymphoid tissue—acquired immunodeficiency syndrome	0.0109	0.0411	CbGeAlD
Ketotifen—PGD—blood plasma—acquired immunodeficiency syndrome	0.0106	0.0402	CbGeAlD
Ketotifen—PDE7A—nervous system—acquired immunodeficiency syndrome	0.0083	0.0314	CbGeAlD
Ketotifen—PDE7A—central nervous system—acquired immunodeficiency syndrome	0.00799	0.0302	CbGeAlD
Ketotifen—PDE7B—lung—acquired immunodeficiency syndrome	0.00784	0.0297	CbGeAlD
Ketotifen—PDE7B—nervous system—acquired immunodeficiency syndrome	0.00726	0.0275	CbGeAlD
Ketotifen—PDE7B—central nervous system—acquired immunodeficiency syndrome	0.00699	0.0264	CbGeAlD
Ketotifen—PDE8B—vagina—acquired immunodeficiency syndrome	0.0066	0.025	CbGeAlD
Ketotifen—PDE8A—blood—acquired immunodeficiency syndrome	0.0064	0.0242	CbGeAlD
Ketotifen—PDE7A—brain—acquired immunodeficiency syndrome	0.00635	0.024	CbGeAlD
Ketotifen—PDE8B—lung—acquired immunodeficiency syndrome	0.00624	0.0236	CbGeAlD
Ketotifen—PDE8A—spinal cord—acquired immunodeficiency syndrome	0.00617	0.0233	CbGeAlD
Ketotifen—PDE8A—vagina—acquired immunodeficiency syndrome	0.00594	0.0225	CbGeAlD
Ketotifen—PGD—retina—acquired immunodeficiency syndrome	0.00582	0.022	CbGeAlD
Ketotifen—PDE8B—nervous system—acquired immunodeficiency syndrome	0.00578	0.0219	CbGeAlD
Ketotifen—PDE8A—lung—acquired immunodeficiency syndrome	0.00561	0.0212	CbGeAlD
Ketotifen—PDE8B—central nervous system—acquired immunodeficiency syndrome	0.00556	0.021	CbGeAlD
Ketotifen—PDE7B—brain—acquired immunodeficiency syndrome	0.00555	0.021	CbGeAlD
Ketotifen—PDE7B—lymph node—acquired immunodeficiency syndrome	0.00536	0.0203	CbGeAlD
Ketotifen—PDE4C—nervous system—acquired immunodeficiency syndrome	0.00535	0.0202	CbGeAlD
Ketotifen—PDE4C—central nervous system—acquired immunodeficiency syndrome	0.00515	0.0195	CbGeAlD
Ketotifen—PGD—skin of body—acquired immunodeficiency syndrome	0.00511	0.0193	CbGeAlD
Ketotifen—PDE4D—lung—acquired immunodeficiency syndrome	0.00509	0.0192	CbGeAlD
Ketotifen—PDE4A—lung—acquired immunodeficiency syndrome	0.0045	0.017	CbGeAlD
Ketotifen—PDE8B—brain—acquired immunodeficiency syndrome	0.00442	0.0167	CbGeAlD
Ketotifen—PDE8B—lymph node—acquired immunodeficiency syndrome	0.00427	0.0161	CbGeAlD
Ketotifen—PGD—lymphoid tissue—acquired immunodeficiency syndrome	0.00414	0.0156	CbGeAlD
Ketotifen—PDE4C—brain—acquired immunodeficiency syndrome	0.00409	0.0155	CbGeAlD
Ketotifen—PGD—digestive system—acquired immunodeficiency syndrome	0.00408	0.0155	CbGeAlD
Ketotifen—PDE8A—brain—acquired immunodeficiency syndrome	0.00397	0.015	CbGeAlD
Ketotifen—PGD—blood—acquired immunodeficiency syndrome	0.00389	0.0147	CbGeAlD
Ketotifen—PDE8A—lymph node—acquired immunodeficiency syndrome	0.00384	0.0145	CbGeAlD
Ketotifen—PGD—bone marrow—acquired immunodeficiency syndrome	0.00377	0.0142	CbGeAlD
Ketotifen—PGD—spinal cord—acquired immunodeficiency syndrome	0.00375	0.0142	CbGeAlD
Ketotifen—PGD—vagina—acquired immunodeficiency syndrome	0.00361	0.0136	CbGeAlD
Ketotifen—PDE4D—brain—acquired immunodeficiency syndrome	0.0036	0.0136	CbGeAlD
Ketotifen—PDE4D—lymph node—acquired immunodeficiency syndrome	0.00348	0.0132	CbGeAlD
Ketotifen—PGD—lung—acquired immunodeficiency syndrome	0.00341	0.0129	CbGeAlD
Ketotifen—PDE4B—lymphoid tissue—acquired immunodeficiency syndrome	0.00325	0.0123	CbGeAlD
Ketotifen—PDE4A—brain—acquired immunodeficiency syndrome	0.00319	0.0121	CbGeAlD
Ketotifen—PGD—nervous system—acquired immunodeficiency syndrome	0.00316	0.012	CbGeAlD
Ketotifen—PDE4A—lymph node—acquired immunodeficiency syndrome	0.00308	0.0116	CbGeAlD
Ketotifen—PDE4B—blood—acquired immunodeficiency syndrome	0.00306	0.0116	CbGeAlD
Ketotifen—PGD—central nervous system—acquired immunodeficiency syndrome	0.00304	0.0115	CbGeAlD
Ketotifen—PDE4B—bone marrow—acquired immunodeficiency syndrome	0.00296	0.0112	CbGeAlD
Ketotifen—PDE4B—spinal cord—acquired immunodeficiency syndrome	0.00295	0.0112	CbGeAlD
Ketotifen—PDE4B—vagina—acquired immunodeficiency syndrome	0.00284	0.0107	CbGeAlD
Ketotifen—PDE4B—lung—acquired immunodeficiency syndrome	0.00268	0.0102	CbGeAlD
Ketotifen—PDE4B—nervous system—acquired immunodeficiency syndrome	0.00249	0.0094	CbGeAlD
Ketotifen—PGD—brain—acquired immunodeficiency syndrome	0.00241	0.00914	CbGeAlD
Ketotifen—PDE4B—central nervous system—acquired immunodeficiency syndrome	0.00239	0.00905	CbGeAlD
Ketotifen—PGD—lymph node—acquired immunodeficiency syndrome	0.00233	0.00883	CbGeAlD
Ketotifen—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00199	0.00314	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.00199	0.00314	CcSEcCtD
Ketotifen—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.00199	0.00313	CcSEcCtD
Ketotifen—Epistaxis—Saquinavir—acquired immunodeficiency syndrome	0.00199	0.00313	CcSEcCtD
Ketotifen—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.00197	0.00311	CcSEcCtD
Ketotifen—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.00196	0.00309	CcSEcCtD
Ketotifen—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00195	0.00306	CcSEcCtD
Ketotifen—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.00193	0.00304	CcSEcCtD
Ketotifen—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.00192	0.00303	CcSEcCtD
Ketotifen—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.0019	0.00299	CcSEcCtD
Ketotifen—PDE4B—brain—acquired immunodeficiency syndrome	0.0019	0.00719	CbGeAlD
Ketotifen—Tension—Efavirenz—acquired immunodeficiency syndrome	0.0019	0.00299	CcSEcCtD
Ketotifen—Epistaxis—Lamivudine—acquired immunodeficiency syndrome	0.0019	0.00298	CcSEcCtD
Ketotifen—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.00189	0.00298	CcSEcCtD
Ketotifen—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00188	0.00296	CcSEcCtD
Ketotifen—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00188	0.00296	CcSEcCtD
Ketotifen—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.00188	0.00296	CcSEcCtD
Ketotifen—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.00187	0.00295	CcSEcCtD
Ketotifen—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00187	0.00294	CcSEcCtD
Ketotifen—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00186	0.00293	CcSEcCtD
Ketotifen—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.00186	0.00293	CcSEcCtD
Ketotifen—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00185	0.00292	CcSEcCtD
Ketotifen—HRH1—digestive system—acquired immunodeficiency syndrome	0.00185	0.00699	CbGeAlD
Ketotifen—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00185	0.00291	CcSEcCtD
Ketotifen—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00184	0.0029	CcSEcCtD
Ketotifen—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00184	0.0029	CcSEcCtD
Ketotifen—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00184	0.00289	CcSEcCtD
Ketotifen—PDE4B—lymph node—acquired immunodeficiency syndrome	0.00184	0.00694	CbGeAlD
Ketotifen—Syncope—Indinavir—acquired immunodeficiency syndrome	0.00183	0.00289	CcSEcCtD
Ketotifen—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00183	0.00288	CcSEcCtD
Ketotifen—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00183	0.00288	CcSEcCtD
Ketotifen—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00181	0.00286	CcSEcCtD
Ketotifen—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.0018	0.00284	CcSEcCtD
Ketotifen—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.0018	0.00283	CcSEcCtD
Ketotifen—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.0018	0.00283	CcSEcCtD
Ketotifen—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.00179	0.00282	CcSEcCtD
Ketotifen—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00179	0.00281	CcSEcCtD
Ketotifen—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00177	0.00279	CcSEcCtD
Ketotifen—Pain—Stavudine—acquired immunodeficiency syndrome	0.00177	0.00278	CcSEcCtD
Ketotifen—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00177	0.00278	CcSEcCtD
Ketotifen—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00176	0.00277	CcSEcCtD
Ketotifen—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00175	0.00275	CcSEcCtD
Ketotifen—Pain—Abacavir—acquired immunodeficiency syndrome	0.00174	0.00274	CcSEcCtD
Ketotifen—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.00173	0.00273	CcSEcCtD
Ketotifen—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.00171	0.00269	CcSEcCtD
Ketotifen—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.0017	0.00268	CcSEcCtD
Ketotifen—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.0017	0.00268	CcSEcCtD
Ketotifen—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00268	CcSEcCtD
Ketotifen—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00169	0.00267	CcSEcCtD
Ketotifen—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00169	0.00266	CcSEcCtD
Ketotifen—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00169	0.00266	CcSEcCtD
Ketotifen—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00169	0.00266	CcSEcCtD
Ketotifen—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00168	0.00265	CcSEcCtD
Ketotifen—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00168	0.00264	CcSEcCtD
Ketotifen—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00167	0.00263	CcSEcCtD
Ketotifen—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00166	0.00262	CcSEcCtD
Ketotifen—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.00166	0.00262	CcSEcCtD
Ketotifen—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00166	0.00261	CcSEcCtD
Ketotifen—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00166	0.00261	CcSEcCtD
Ketotifen—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00165	0.00259	CcSEcCtD
Ketotifen—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00165	0.00259	CcSEcCtD
Ketotifen—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00164	0.00259	CcSEcCtD
Ketotifen—Shock—Indinavir—acquired immunodeficiency syndrome	0.00164	0.00259	CcSEcCtD
Ketotifen—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00164	0.00258	CcSEcCtD
Ketotifen—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00164	0.00258	CcSEcCtD
Ketotifen—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00164	0.00258	CcSEcCtD
Ketotifen—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00163	0.00257	CcSEcCtD
Ketotifen—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00163	0.00257	CcSEcCtD
Ketotifen—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00163	0.00257	CcSEcCtD
Ketotifen—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00163	0.00257	CcSEcCtD
Ketotifen—HRH1—vagina—acquired immunodeficiency syndrome	0.00163	0.00617	CbGeAlD
Ketotifen—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00163	0.00256	CcSEcCtD
Ketotifen—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00163	0.00256	CcSEcCtD
Ketotifen—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00162	0.00256	CcSEcCtD
Ketotifen—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00162	0.00255	CcSEcCtD
Ketotifen—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00161	0.00254	CcSEcCtD
Ketotifen—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00161	0.00253	CcSEcCtD
Ketotifen—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00161	0.00253	CcSEcCtD
Ketotifen—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00161	0.00253	CcSEcCtD
Ketotifen—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.0016	0.00251	CcSEcCtD
Ketotifen—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.0016	0.00251	CcSEcCtD
Ketotifen—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00155	0.00244	CcSEcCtD
Ketotifen—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00155	0.00244	CcSEcCtD
Ketotifen—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.00243	CcSEcCtD
Ketotifen—HRH1—lung—acquired immunodeficiency syndrome	0.00154	0.00584	CbGeAlD
Ketotifen—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00154	0.00243	CcSEcCtD
Ketotifen—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.00242	CcSEcCtD
Ketotifen—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.00242	CcSEcCtD
Ketotifen—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00153	0.00242	CcSEcCtD
Ketotifen—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00153	0.0024	CcSEcCtD
Ketotifen—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00151	0.00238	CcSEcCtD
Ketotifen—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00151	0.00238	CcSEcCtD
Ketotifen—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00151	0.00238	CcSEcCtD
Ketotifen—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00237	CcSEcCtD
Ketotifen—Rash—Didanosine—acquired immunodeficiency syndrome	0.0015	0.00236	CcSEcCtD
Ketotifen—Infection—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.00236	CcSEcCtD
Ketotifen—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00236	CcSEcCtD
Ketotifen—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0015	0.00236	CcSEcCtD
Ketotifen—Headache—Didanosine—acquired immunodeficiency syndrome	0.00149	0.00235	CcSEcCtD
Ketotifen—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00148	0.00234	CcSEcCtD
Ketotifen—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00234	CcSEcCtD
Ketotifen—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00148	0.00233	CcSEcCtD
Ketotifen—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00148	0.00233	CcSEcCtD
Ketotifen—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00148	0.00232	CcSEcCtD
Ketotifen—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00147	0.00231	CcSEcCtD
Ketotifen—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00147	0.00231	CcSEcCtD
Ketotifen—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00146	0.0023	CcSEcCtD
Ketotifen—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00146	0.0023	CcSEcCtD
Ketotifen—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00228	CcSEcCtD
Ketotifen—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00144	0.00227	CcSEcCtD
Ketotifen—HRH1—nervous system—acquired immunodeficiency syndrome	0.00143	0.00541	CbGeAlD
Ketotifen—Pain—Indinavir—acquired immunodeficiency syndrome	0.00143	0.00225	CcSEcCtD
Ketotifen—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00143	0.00225	CcSEcCtD
Ketotifen—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00143	0.00225	CcSEcCtD
Ketotifen—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00224	CcSEcCtD
Ketotifen—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00224	CcSEcCtD
Ketotifen—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00142	0.00223	CcSEcCtD
Ketotifen—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00142	0.00223	CcSEcCtD
Ketotifen—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00142	0.00223	CcSEcCtD
Ketotifen—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00223	CcSEcCtD
Ketotifen—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00141	0.00223	CcSEcCtD
Ketotifen—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00141	0.00223	CcSEcCtD
Ketotifen—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00222	CcSEcCtD
Ketotifen—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.0014	0.00221	CcSEcCtD
Ketotifen—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00139	0.00219	CcSEcCtD
Ketotifen—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00217	CcSEcCtD
Ketotifen—HRH1—central nervous system—acquired immunodeficiency syndrome	0.00138	0.00521	CbGeAlD
Ketotifen—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00137	0.00216	CcSEcCtD
Ketotifen—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00216	CcSEcCtD
Ketotifen—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00137	0.00216	CcSEcCtD
Ketotifen—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00137	0.00215	CcSEcCtD
Ketotifen—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00137	0.00215	CcSEcCtD
Ketotifen—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00137	0.00215	CcSEcCtD
Ketotifen—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00137	0.00215	CcSEcCtD
Ketotifen—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00136	0.00214	CcSEcCtD
Ketotifen—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.00213	CcSEcCtD
Ketotifen—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00135	0.00212	CcSEcCtD
Ketotifen—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00135	0.00212	CcSEcCtD
Ketotifen—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00135	0.00212	CcSEcCtD
Ketotifen—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00135	0.00212	CcSEcCtD
Ketotifen—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00134	0.00211	CcSEcCtD
Ketotifen—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00134	0.00211	CcSEcCtD
Ketotifen—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00133	0.0021	CcSEcCtD
Ketotifen—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00209	CcSEcCtD
Ketotifen—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00208	CcSEcCtD
Ketotifen—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00132	0.00208	CcSEcCtD
Ketotifen—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00132	0.00208	CcSEcCtD
Ketotifen—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00132	0.00207	CcSEcCtD
Ketotifen—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00207	CcSEcCtD
Ketotifen—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00131	0.00207	CcSEcCtD
Ketotifen—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00206	CcSEcCtD
Ketotifen—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00131	0.00206	CcSEcCtD
Ketotifen—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00131	0.00206	CcSEcCtD
Ketotifen—Rash—Stavudine—acquired immunodeficiency syndrome	0.0013	0.00205	CcSEcCtD
Ketotifen—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.0013	0.00205	CcSEcCtD
Ketotifen—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.0013	0.00204	CcSEcCtD
Ketotifen—Headache—Stavudine—acquired immunodeficiency syndrome	0.00129	0.00204	CcSEcCtD
Ketotifen—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00129	0.00204	CcSEcCtD
Ketotifen—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00129	0.00203	CcSEcCtD
Ketotifen—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00129	0.00203	CcSEcCtD
Ketotifen—Rash—Abacavir—acquired immunodeficiency syndrome	0.00128	0.00202	CcSEcCtD
Ketotifen—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00128	0.00202	CcSEcCtD
Ketotifen—Headache—Abacavir—acquired immunodeficiency syndrome	0.00127	0.00201	CcSEcCtD
Ketotifen—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.002	CcSEcCtD
Ketotifen—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00127	0.002	CcSEcCtD
Ketotifen—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00127	0.002	CcSEcCtD
Ketotifen—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00199	CcSEcCtD
Ketotifen—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.00199	CcSEcCtD
Ketotifen—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00198	CcSEcCtD
Ketotifen—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00197	CcSEcCtD
Ketotifen—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.00197	CcSEcCtD
Ketotifen—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.00196	CcSEcCtD
Ketotifen—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.00196	CcSEcCtD
Ketotifen—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00124	0.00195	CcSEcCtD
Ketotifen—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00123	0.00194	CcSEcCtD
Ketotifen—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00123	0.00194	CcSEcCtD
Ketotifen—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00123	0.00193	CcSEcCtD
Ketotifen—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00123	0.00193	CcSEcCtD
Ketotifen—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00191	CcSEcCtD
Ketotifen—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00121	0.0019	CcSEcCtD
Ketotifen—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.0019	CcSEcCtD
Ketotifen—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.00189	CcSEcCtD
Ketotifen—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00188	CcSEcCtD
Ketotifen—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00119	0.00188	CcSEcCtD
Ketotifen—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00188	CcSEcCtD
Ketotifen—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00188	CcSEcCtD
Ketotifen—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00187	CcSEcCtD
Ketotifen—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00118	0.00186	CcSEcCtD
Ketotifen—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00183	CcSEcCtD
Ketotifen—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00181	CcSEcCtD
Ketotifen—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00115	0.00181	CcSEcCtD
Ketotifen—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00114	0.0018	CcSEcCtD
Ketotifen—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00114	0.0018	CcSEcCtD
Ketotifen—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00114	0.0018	CcSEcCtD
Ketotifen—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00114	0.00179	CcSEcCtD
Ketotifen—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00178	CcSEcCtD
Ketotifen—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00178	CcSEcCtD
Ketotifen—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00112	0.00177	CcSEcCtD
Ketotifen—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00112	0.00176	CcSEcCtD
Ketotifen—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00175	CcSEcCtD
Ketotifen—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.0011	0.00174	CcSEcCtD
Ketotifen—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00174	CcSEcCtD
Ketotifen—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00174	CcSEcCtD
Ketotifen—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.0011	0.00173	CcSEcCtD
Ketotifen—Pain—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00173	CcSEcCtD
Ketotifen—HRH1—brain—acquired immunodeficiency syndrome	0.00109	0.00413	CbGeAlD
Ketotifen—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.0017	CcSEcCtD
Ketotifen—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00107	0.00168	CcSEcCtD
Ketotifen—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00168	CcSEcCtD
Ketotifen—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00107	0.00168	CcSEcCtD
Ketotifen—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00167	CcSEcCtD
Ketotifen—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00167	CcSEcCtD
Ketotifen—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00106	0.00167	CcSEcCtD
Ketotifen—HRH1—lymph node—acquired immunodeficiency syndrome	0.00106	0.00399	CbGeAlD
Ketotifen—Rash—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00166	CcSEcCtD
Ketotifen—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00166	CcSEcCtD
Ketotifen—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00105	0.00165	CcSEcCtD
Ketotifen—Headache—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00165	CcSEcCtD
Ketotifen—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00164	CcSEcCtD
Ketotifen—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00163	CcSEcCtD
Ketotifen—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.0016	CcSEcCtD
Ketotifen—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.0016	CcSEcCtD
Ketotifen—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.0016	CcSEcCtD
Ketotifen—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.001	0.00158	CcSEcCtD
Ketotifen—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000998	0.00157	CcSEcCtD
Ketotifen—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000995	0.00157	CcSEcCtD
Ketotifen—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000994	0.00156	CcSEcCtD
Ketotifen—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000992	0.00156	CcSEcCtD
Ketotifen—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000988	0.00156	CcSEcCtD
Ketotifen—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000987	0.00156	CcSEcCtD
Ketotifen—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00096	0.00151	CcSEcCtD
Ketotifen—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000955	0.0015	CcSEcCtD
Ketotifen—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000952	0.0015	CcSEcCtD
Ketotifen—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000951	0.0015	CcSEcCtD
Ketotifen—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00095	0.0015	CcSEcCtD
Ketotifen—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000946	0.00149	CcSEcCtD
Ketotifen—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000937	0.00148	CcSEcCtD
Ketotifen—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000923	0.00145	CcSEcCtD
Ketotifen—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000919	0.00145	CcSEcCtD
Ketotifen—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000907	0.00143	CcSEcCtD
Ketotifen—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000897	0.00141	CcSEcCtD
Ketotifen—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000888	0.0014	CcSEcCtD
Ketotifen—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000887	0.0014	CcSEcCtD
Ketotifen—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00088	0.00139	CcSEcCtD
Ketotifen—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000879	0.00138	CcSEcCtD
Ketotifen—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000877	0.00138	CcSEcCtD
Ketotifen—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000874	0.00138	CcSEcCtD
Ketotifen—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000854	0.00135	CcSEcCtD
Ketotifen—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000847	0.00133	CcSEcCtD
Ketotifen—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000847	0.00133	CcSEcCtD
Ketotifen—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000846	0.00133	CcSEcCtD
Ketotifen—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000842	0.00133	CcSEcCtD
Ketotifen—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000829	0.00131	CcSEcCtD
Ketotifen—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000815	0.00128	CcSEcCtD
Ketotifen—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000808	0.00127	CcSEcCtD
Ketotifen—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000807	0.00127	CcSEcCtD
Ketotifen—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000803	0.00126	CcSEcCtD
Ketotifen—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000798	0.00126	CcSEcCtD
Ketotifen—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000761	0.0012	CcSEcCtD
Ketotifen—PDE8B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000429	0.00426	CbGpPWpGaD
Ketotifen—PDE8A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000429	0.00426	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000425	0.00422	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000424	0.00421	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000424	0.00421	CbGpPWpGaD
Ketotifen—PDE8B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000422	0.0042	CbGpPWpGaD
Ketotifen—PDE8A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000422	0.0042	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000414	0.00412	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000404	0.00401	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000402	0.004	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000394	0.00392	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000393	0.00391	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000389	0.00387	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000389	0.00387	CbGpPWpGaD
Ketotifen—PDE8B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000386	0.00384	CbGpPWpGaD
Ketotifen—PDE8A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000386	0.00384	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000384	0.00381	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000384	0.00381	CbGpPWpGaD
Ketotifen—PDE7B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000382	0.0038	CbGpPWpGaD
Ketotifen—PDE7B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000377	0.00374	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000365	0.00363	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000356	0.00353	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000356	0.00353	CbGpPWpGaD
Ketotifen—PDE7A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000355	0.00353	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000351	0.00349	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000351	0.00349	CbGpPWpGaD
Ketotifen—PDE7A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00035	0.00348	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000347	0.00345	CbGpPWpGaD
Ketotifen—PDE7B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000344	0.00342	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000342	0.0034	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000339	0.00337	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000325	0.00323	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000324	0.00322	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000323	0.00321	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000322	0.0032	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000322	0.0032	CbGpPWpGaD
Ketotifen—PDE7A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00032	0.00318	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000318	0.00316	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000317	0.00315	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000313	0.00311	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000311	0.00309	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000311	0.00309	CbGpPWpGaD
Ketotifen—PGD—Disease—CXCR4—acquired immunodeficiency syndrome	0.000308	0.00306	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000306	0.00304	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000304	0.00302	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000304	0.00302	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000302	0.003	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000302	0.003	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000302	0.003	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000302	0.003	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000295	0.00293	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000294	0.00292	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000291	0.00289	CbGpPWpGaD
Ketotifen—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00029	0.00288	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000287	0.00285	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000287	0.00285	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000283	0.00281	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000282	0.0028	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000281	0.00279	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000276	0.00275	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000276	0.00275	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000275	0.00273	CbGpPWpGaD
Ketotifen—HRH1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000273	0.00271	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000271	0.00269	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000271	0.00269	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00027	0.00268	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00027	0.00268	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000269	0.00268	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000268	0.00267	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000267	0.00265	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000265	0.00263	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000265	0.00263	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000258	0.00256	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000258	0.00256	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000256	0.00254	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000252	0.00251	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000252	0.00251	CbGpPWpGaD
Ketotifen—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000252	0.0025	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000251	0.00249	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000251	0.00249	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000249	0.00248	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000249	0.00247	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000248	0.00247	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000245	0.00243	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000244	0.00242	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000241	0.00239	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000241	0.00239	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000238	0.00237	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000238	0.00237	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000234	0.00232	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000234	0.00232	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000233	0.00232	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000233	0.00232	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000233	0.00231	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000232	0.0023	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00023	0.00229	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00023	0.00229	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000229	0.00228	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000229	0.00228	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000228	0.00227	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000227	0.00225	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000227	0.00225	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000225	0.00224	CbGpPWpGaD
Ketotifen—PDE8B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000223	0.00222	CbGpPWpGaD
Ketotifen—PDE8A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000223	0.00222	CbGpPWpGaD
Ketotifen—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	0.000222	0.0022	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000216	0.00214	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000212	0.00211	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000212	0.00211	CbGpPWpGaD
Ketotifen—PGD—Disease—CCR5—acquired immunodeficiency syndrome	0.000211	0.0021	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00021	0.00209	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000209	0.00208	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000209	0.00207	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000207	0.00206	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000207	0.00206	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000207	0.00206	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000205	0.00204	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000203	0.00201	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000203	0.00201	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000202	0.00201	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000202	0.002	CbGpPWpGaD
Ketotifen—PDE7B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000199	0.00198	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000199	0.00197	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000192	0.00191	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000192	0.00191	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000191	0.00189	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000189	0.00188	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000189	0.00188	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000189	0.00188	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000188	0.00187	CbGpPWpGaD
Ketotifen—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000187	0.00186	CbGpPWpGaD
Ketotifen—PDE7A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000185	0.00184	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000185	0.00184	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000183	0.00182	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000182	0.0018	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000181	0.0018	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00018	0.00179	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000178	0.00177	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000178	0.00177	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000178	0.00177	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000178	0.00176	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000175	0.00174	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000174	0.00173	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000174	0.00173	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000174	0.00173	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000173	0.00172	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000172	0.00171	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000172	0.00171	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00017	0.00168	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000168	0.00167	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000167	0.00166	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000165	0.00164	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000163	0.00162	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000163	0.00162	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000161	0.0016	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00016	0.00159	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00016	0.00159	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000159	0.00158	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000159	0.00158	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000157	0.00156	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000157	0.00156	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000151	0.0015	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000147	0.00146	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000145	0.00144	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000144	0.00143	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000142	0.00141	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000142	0.00141	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000135	0.00135	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000135	0.00134	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000135	0.00134	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000133	0.00132	CbGpPWpGaD
Ketotifen—PGD—Disease—CD4—acquired immunodeficiency syndrome	0.000132	0.00132	CbGpPWpGaD
Ketotifen—PGD—Metabolism—ALB—acquired immunodeficiency syndrome	0.000126	0.00125	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000125	0.00124	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000125	0.00124	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000124	0.00123	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000122	0.00122	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000122	0.00121	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000121	0.0012	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00012	0.00119	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00012	0.00119	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000119	0.00118	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000119	0.00118	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000112	0.00111	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000109	0.00109	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000108	0.00107	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000107	0.00107	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000107	0.00106	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000107	0.00106	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000107	0.00106	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000106	0.00106	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000105	0.00104	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000103	0.00102	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000103	0.00102	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000103	0.00102	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000101	0.00101	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000101	0.000999	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000101	0.000999	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.99e-05	0.000992	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.92e-05	0.000986	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.87e-05	0.000981	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.74e-05	0.000968	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	9.71e-05	0.000965	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.53e-05	0.000947	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.53e-05	0.000946	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.38e-05	0.000932	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	9.29e-05	0.000923	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.27e-05	0.000921	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.24e-05	0.000918	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.13e-05	0.000907	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.13e-05	0.000907	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.07e-05	0.000901	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.58e-05	0.000853	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.39e-05	0.000834	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	7.65e-05	0.00076	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	7.54e-05	0.000749	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	7.35e-05	0.00073	CbGpPWpGaD
Ketotifen—PGD—Disease—IL6—acquired immunodeficiency syndrome	7.16e-05	0.000712	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.04e-05	0.000699	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.04e-05	0.000699	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.95e-05	0.00069	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6.89e-05	0.000685	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	6.84e-05	0.00068	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.47e-05	0.000643	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.43e-05	0.000639	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.35e-05	0.00063	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.27e-05	0.000623	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.26e-05	0.000622	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.83e-05	0.00058	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.74e-05	0.00057	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.63e-05	0.000559	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.6e-05	0.000557	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.4e-05	0.000536	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.4e-05	0.000536	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.36e-05	0.000532	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.33e-05	0.00053	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.96e-05	0.000493	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.93e-05	0.00049	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.1e-05	0.000408	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.04e-05	0.000402	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.98e-05	0.000396	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.8e-05	0.000378	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.7e-05	0.000367	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.62e-05	0.000359	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.31e-05	0.000329	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.15e-05	0.000313	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.91e-05	0.00029	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.14e-05	0.000212	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.13e-05	0.000211	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.26e-05	0.000125	CbGpPWpGaD
